The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

Irit Avivi; Moshe E. Gatt; Efrat Luttwak; Hila Magen; Najib Dally; Yael C. Cohen; Noam Benyamini; Noa Lavi

doi:10.1016/j.leukres.2020.106429

The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

Irit Avivi
, Moshe E. Gatt
, Efrat Luttwak
, Hila Magen
, Najib Dally
, Yael C. Cohen
, Noam Benyamini
, Noa Lavi

Bar-Ilan University - Azrieli Faculty of Medicine

Tel Aviv Sourasky Medical Center
Tel Aviv University
Hadassah University Medical Centre
Hebrew University of Jerusalem
Sheba Medical Center at Tel Hashomer
Rebecca Sieff Government Hospital
Technion-Israel Institute of Technology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Article number	106429
Journal	Leukemia Research
Volume	97
DOIs	https://doi.org/10.1016/j.leukres.2020.106429
State	Published - Oct 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Levofloxacin prophylaxis
Venetoclax
relapsed/refractory multiple myeloma
t(11;14)

Access to Document

10.1016/j.leukres.2020.106429

Cite this

@article{008a0048ab204bcaa8597a9b695fd545,

title = "The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data",

keywords = "Levofloxacin prophylaxis, Venetoclax, relapsed/refractory multiple myeloma, t(11;14)",

author = "Irit Avivi and Gatt, \{Moshe E.\} and Efrat Luttwak and Hila Magen and Najib Dally and Cohen, \{Yael C.\} and Noam Benyamini and Noa Lavi",

year = "2020",

month = oct,

doi = "10.1016/j.leukres.2020.106429",

language = "אנגלית",

volume = "97",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias

T2 - Real-life data

AU - Avivi, Irit

AU - Gatt, Moshe E.

AU - Luttwak, Efrat

AU - Magen, Hila

AU - Dally, Najib

AU - Cohen, Yael C.

AU - Benyamini, Noam

AU - Lavi, Noa

PY - 2020/10

Y1 - 2020/10

KW - Levofloxacin prophylaxis

KW - Venetoclax

KW - relapsed/refractory multiple myeloma

KW - t(11;14)

UR - https://www.scopus.com/pages/publications/85089809782

U2 - 10.1016/j.leukres.2020.106429

DO - 10.1016/j.leukres.2020.106429

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 32861018

AN - SCOPUS:85089809782

SN - 0145-2126

VL - 97

JO - Leukemia Research

JF - Leukemia Research

M1 - 106429

ER -

The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

UN SDGs

Keywords

Access to Document

Other files and links

Cite this